A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Condition: Heart Failure Interventions: Drug: Finerenone; Drug: Empagliflozin Sponsors: Colorado Prevention Center; Saint Luke's Hospital of Kansas City; Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials